Hepatitis C virus and hepatocarcinogenesis

被引:42
作者
Hayashi, J
Aoki, H
Arakawa, Y
Hino, O
机构
[1] Inst Canc Res, Dept Expt Pathol, Toshima Ku, Tokyo 1708455, Japan
[2] Nihon Univ, Sch Med, Dept Internal Med 3, Tokyo, Japan
关键词
hepatitis C virus; hepatocarcinogenesis; hepatocellular carcinoma; hepatitis; signal transduction;
D O I
10.1159/000024962
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Although human hepatocellular carcinoma (HCC) is one of the most common types of tumors in the world, the molecular mechanisms underlying hepatitis-C-related human hepatocarcinogenesis are still not clear. HCC is accompanied by virus infections in most cases, and it is suggested that hepatitis B virus and hepatitis C virus (HCV) significantly influence the oncogenic process. The persistence of inflammation following HCV infection is reportedly related to carcinogenesis, and the mechanism of chronic inflammation has been approached by taking viral, immunologic, cytokine and apoptotic responses into consideration. With the progress made in molecular biology, the functional abnormality of oncogenes/tumor suppressor genes has been identified and, apart from the p53 gene, involvement of the IGF-II gene has also been described recently. Furthermore, it has been suggested that uncontrolled proliferation of cancer cells might be based on abnormal regulation of intracellular signal transduction pathways. Here we review the cutting edge of molecular hepatitis C virology in terms of virus-cell interactions, which may contribute to the development of human HCCs. We also discuss the recent progress made in the molecular and cell biology of human hepatocarcinogenesis.
引用
收藏
页码:205 / 210
页数:6
相关论文
共 44 条
  • [1] ISOLATION OF A CDNA CLONE DERIVED FROM A BLOOD-BORNE NON-A, NON-B VIRAL-HEPATITIS GENOME
    CHOO, QL
    KUO, G
    WEINER, AJ
    OVERBY, LR
    BRADLEY, DW
    HOUGHTON, M
    [J]. SCIENCE, 1989, 244 (4902) : 359 - 362
  • [2] URINARY EPIDERMAL GROWTH-FACTOR RECEPTOR-BINDING GROWTH-FACTORS IN PATIENTS WITH CANCERS OF THE DIGESTIVE-TRACT
    CHUANG, LY
    HUNG, WC
    YANG, ML
    CHANG, CC
    TSAI, JF
    [J]. CLINICAL BIOCHEMISTRY, 1994, 27 (06) : 485 - 489
  • [3] de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847
  • [4] M6P/IGF2R GENE IS MUTATED IN HUMAN HEPATOCELLULAR CARCINOMAS WITH LOSS OF HETEROZYGOSITY
    DESOUZA, AT
    HANKINS, GR
    WASHINGTON, MK
    ORTON, TC
    JIRTLE, RL
    [J]. NATURE GENETICS, 1995, 11 (04) : 447 - 449
  • [5] DESOUZA AT, 1995, ONCOGENE, V10, P1725
  • [6] THE HEPATITIS-B VIRUS HBX PROTEIN IS A DUAL-SPECIFICITY CYTOPLASMIC ACTIVATOR OF RAS AND NUCLEAR ACTIVATOR OF TRANSCRIPTION FACTORS
    DORIA, M
    KLEIN, N
    LUCITO, R
    SCHNEIDER, RJ
    [J]. EMBO JOURNAL, 1995, 14 (19) : 4747 - 4757
  • [7] 12-O-tetradecanoylphorbol-13-acetate activates the Ras/extracellular signal-regulated kinase (ERK) signaling pathway upstream of SOS involving serine phosphorylation of Shc in NIH3T3 cells
    El-Shemerly, MYM
    Besser, D
    Nagasawa, M
    Nagamine, Y
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (49) : 30599 - 30602
  • [8] Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein
    Gale, MJ
    Korth, MJ
    Tang, NM
    Tan, SL
    Hopkins, DA
    Dever, TE
    Polyak, SJ
    Gretch, DR
    Katze, MG
    [J]. VIROLOGY, 1997, 230 (02) : 217 - 227
  • [9] Hino O, 1998, INT CONGR SER, V4, P35
  • [10] Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection
    Hiroishi, K
    Kita, H
    Kojima, M
    Okamoto, H
    Moriyama, T
    Kaneko, T
    Ishikawa, T
    Ohnishi, S
    Aikawa, T
    Tanaka, N
    Yazaki, Y
    Mitamura, K
    Imawari, M
    [J]. HEPATOLOGY, 1997, 25 (03) : 705 - 712